149 related articles for article (PubMed ID: 23542114)
21. Arsenic trioxide sensitizes cancer stem cells to chemoradiotherapy. A new approach in the treatment of inoperable glioblastoma multiforme.
Tomuleasa C; Soritau O; Kacso G; Fischer-Fodor E; Cocis A; Ioani H; Timis T; Petrescu M; Cernea D; Virag P; Irimie A; Florian IS
J BUON; 2010; 15(4):758-62. PubMed ID: 21229642
[TBL] [Abstract][Full Text] [Related]
22. A combined gene signature of hypoxia and notch pathway in human glioblastoma and its prognostic relevance.
Irshad K; Mohapatra SK; Srivastava C; Garg H; Mishra S; Dikshit B; Sarkar C; Gupta D; Chandra PS; Chattopadhyay P; Sinha S; Chosdol K
PLoS One; 2015; 10(3):e0118201. PubMed ID: 25734817
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of Notch signaling alters the phenotype of orthotopic tumors formed from glioblastoma multiforme neurosphere cells but does not hamper intracranial tumor growth regardless of endogene Notch pathway signature.
Kristoffersen K; Nedergaard MK; Villingshøj M; Borup R; Broholm H; Kjær A; Poulsen HS; Stockhausen MT
Cancer Biol Ther; 2014 Jul; 15(7):862-77. PubMed ID: 24755988
[TBL] [Abstract][Full Text] [Related]
24. Tetraarsenic oxide-induced inhibition of malignant glioma cell invasion in vitro via a decrease in matrix metalloproteinase secretion and protein kinase B phosphorylation.
Gwak HS; Park MJ; Park IC; Woo SH; Jin HO; Rhee CH; Jung HW
J Neurosurg; 2014 Dec; 121(6):1483-91. PubMed ID: 25303017
[TBL] [Abstract][Full Text] [Related]
25. Regulation of glioblastoma stem cells by retinoic acid: role for Notch pathway inhibition.
Ying M; Wang S; Sang Y; Sun P; Lal B; Goodwin CR; Guerrero-Cazares H; Quinones-Hinojosa A; Laterra J; Xia S
Oncogene; 2011 Aug; 30(31):3454-67. PubMed ID: 21383690
[TBL] [Abstract][Full Text] [Related]
26. Downregulation of RND3/RhoE in glioblastoma patients promotes tumorigenesis through augmentation of notch transcriptional complex activity.
Liu B; Lin X; Yang X; Dong H; Yue X; Andrade KC; Guo Z; Yang J; Wu L; Zhu X; Zhang S; Tian D; Wang J; Cai Q; Chen Q; Mao S; Chen Q; Chang J
Cancer Med; 2015 Sep; 4(9):1404-16. PubMed ID: 26108681
[TBL] [Abstract][Full Text] [Related]
27. Sorafenib selectively depletes human glioblastoma tumor-initiating cells from primary cultures.
Carra E; Barbieri F; Marubbi D; Pattarozzi A; Favoni RE; Florio T; Daga A
Cell Cycle; 2013 Feb; 12(3):491-500. PubMed ID: 23324350
[TBL] [Abstract][Full Text] [Related]
28. PDGFRα depletion attenuates glioblastoma stem cells features by modulation of STAT3, RB1 and multiple oncogenic signals.
Cenciarelli C; Marei HE; Felsani A; Casalbore P; Sica G; Puglisi MA; Cameron AJ; Olivi A; Mangiola A
Oncotarget; 2016 Aug; 7(33):53047-53063. PubMed ID: 27344175
[TBL] [Abstract][Full Text] [Related]
29. Downregulation of TRAP1 sensitizes glioblastoma cells to temozolomide chemotherapy through regulating metabolic reprogramming.
Wu J; Liu Y; Cho K; Dong X; Teng L; Han D; Liu H; Chen X; Chen X; Hou X; Peng F; Bi Y; Shen C; Zhao S
Neuroreport; 2016 Feb; 27(3):136-44. PubMed ID: 26716385
[TBL] [Abstract][Full Text] [Related]
30. Constitutive activation of signal transducer and activator of transcription 3 (STAT3) and nuclear factor κB signaling in glioblastoma cancer stem cells regulates the Notch pathway.
Garner JM; Fan M; Yang CH; Du Z; Sims M; Davidoff AM; Pfeffer LM
J Biol Chem; 2013 Sep; 288(36):26167-26176. PubMed ID: 23902772
[TBL] [Abstract][Full Text] [Related]
31. Neurotensin signaling regulates stem-like traits of glioblastoma stem cells through activation of IL-8/CXCR1/STAT3 pathway.
Zhou J; Yi L; Ouyang Q; Xu L; Cui H; Xu M
Cell Signal; 2014 Dec; 26(12):2896-902. PubMed ID: 25200966
[TBL] [Abstract][Full Text] [Related]
32. Tanshinone IIA inhibits the growth, attenuates the stemness and induces the apoptosis of human glioma stem cells.
Yang L; Guo H; Dong L; Wang L; Liu C; Wang X
Oncol Rep; 2014 Sep; 32(3):1303-11. PubMed ID: 24970314
[TBL] [Abstract][Full Text] [Related]
33. A role for the transcription factor HEY1 in glioblastoma.
Hulleman E; Quarto M; Vernell R; Masserdotti G; Colli E; Kros JM; Levi D; Gaetani P; Tunici P; Finocchiaro G; Baena RR; Capra M; Helin K
J Cell Mol Med; 2009 Jan; 13(1):136-46. PubMed ID: 18363832
[TBL] [Abstract][Full Text] [Related]
34. Honokiol inhibits melanoma stem cells by targeting notch signaling.
Kaushik G; Venugopal A; Ramamoorthy P; Standing D; Subramaniam D; Umar S; Jensen RA; Anant S; Mammen JM
Mol Carcinog; 2015 Dec; 54(12):1710-21. PubMed ID: 25491779
[TBL] [Abstract][Full Text] [Related]
35. The role of STAT3 in glioblastoma progression through dual influences on tumor cells and the immune microenvironment.
Chang N; Ahn SH; Kong DS; Lee HW; Nam DH
Mol Cell Endocrinol; 2017 Aug; 451():53-65. PubMed ID: 28089821
[TBL] [Abstract][Full Text] [Related]
36. STAT3 is essential for the maintenance of neurosphere-initiating tumor cells in patients with glioblastomas: a potential for targeted therapy?
Villalva C; Martin-Lannerée S; Cortes U; Dkhissi F; Wager M; Le Corf A; Tourani JM; Dusanter-Fourt I; Turhan AG; Karayan-Tapon L
Int J Cancer; 2011 Feb; 128(4):826-38. PubMed ID: 20473906
[TBL] [Abstract][Full Text] [Related]
37. PI3K-AKT pathway negatively controls EGFR-dependent DNA-binding activity of Stat3 in glioblastoma multiforme cells.
Ghosh MK; Sharma P; Harbor PC; Rahaman SO; Haque SJ
Oncogene; 2005 Nov; 24(49):7290-300. PubMed ID: 16007122
[TBL] [Abstract][Full Text] [Related]
38. Fluvoxamine, an anti-depressant, inhibits human glioblastoma invasion by disrupting actin polymerization.
Hayashi K; Michiue H; Yamada H; Takata K; Nakayama H; Wei FY; Fujimura A; Tazawa H; Asai A; Ogo N; Miyachi H; Nishiki T; Tomizawa K; Takei K; Matsui H
Sci Rep; 2016 Mar; 6():23372. PubMed ID: 26988603
[TBL] [Abstract][Full Text] [Related]
39. Notch pathway activity identifies cells with cancer stem cell-like properties and correlates with worse survival in lung adenocarcinoma.
Hassan KA; Wang L; Korkaya H; Chen G; Maillard I; Beer DG; Kalemkerian GP; Wicha MS
Clin Cancer Res; 2013 Apr; 19(8):1972-80. PubMed ID: 23444212
[TBL] [Abstract][Full Text] [Related]
40. Targeting cancer stem cells in glioblastoma multiforme using mTOR inhibitors and the differentiating agent all-trans retinoic acid.
Friedman MD; Jeevan DS; Tobias M; Murali R; Jhanwar-Uniyal M
Oncol Rep; 2013 Oct; 30(4):1645-50. PubMed ID: 23877261
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]